|
J Biol Chem, Vol. 273, Issue 38, 24624-24632, September 18, 1998
Differential Coupling of 1-, 2-,
and -Adrenergic Receptors to Mitogen-activated Protein Kinase
Pathways and Differentiation in Transfected PC12 Cells*
Nidhi Gupta
Williams,
Hongying
Zhong, and
Kenneth P.
Minneman
From the Department of Pharmacology, Emory University School of
Medicine, Atlanta, Georgia 30322
 |
ABSTRACT |
Three adrenergic receptor families that
selectively activate three different G proteins
( 1/Gq/11,
2/Gi, and /Gs) were used to
study mitogen-activated protein kinase (MAPK) activation and differentiation in PC12 cells. PC12 cells were stably transfected with
1A-, 2A-, or 1-adrenergic
receptors (ARs) in an inducible expression vector, and subclones were
characterized. Norepinephrine stimulated inositol phosphate formation
in 1A-transfected cells, inhibited cyclic adenosine
3'5'-monophosphate (cAMP) formation in 2A-transfected
cells, and stimulated cAMP formation in 1-transfected cells. Nerve growth factor activated extracellular signal-regulated kinases (ERKs) in all cell lines; however, norepinephrine activated ERKs only in 1A- and 1-transfected cells
but not in 2A-transfected cells. Norepinephrine also
activated c-Jun NH2-terminal kinase and p38 MAPK in
1A-transfected cells but not in 1- or
2A-transfected cells. Norepinephrine caused
differentiation of PC12 cells expressing 1A-ARs but not
those expressing 1- or 2A-ARs. However,
norepinephrine acted synergistically with nerve growth factor in
promoting differentiation of cells expressing 1-ARs.
Whereas ERKs are activated by Gi- but not
Gs-linked receptors in many fibroblastic cell lines, we observed the opposite in PC12 cells. The results show that activation of the different G protein signaling pathways has different effects on
MAPKs and differentiation in PC12 cells, with Gq signaling pathways activating all three major MAPK pathways.
 |
INTRODUCTION |
Although mitogen-activated protein kinase
(MAPK)1 pathways were
originally thought to be activated primarily by growth factor receptors
with intrinsic tyrosine kinase activity, it is now clear that G
protein-coupled receptors (GPCRs) can also activate MAPK pathways
(1-11). GPCRs acting through Gs (12), Gi (1,
2, 4, 5), and Gq/11 (3, 6-8, 10, 14), have all been shown
to activate MAPK, although the mechanisms involved appear to be
dependent on cell phenotype. In some cases, MAPK activation is
downstream of known second messengers such as cAMP (12), Ca2+ (6, 8), and/or protein kinase C (10). In other cells, G - and/or G -subunits may directly or indirectly activate the Ras/Raf pathway (1-5, 11) through adapter proteins, tyrosine kinases,
and/or phosphoinositide 3 kinase (9). MAPK pathways have been shown to
be inhibited by increases in cAMP concentrations in some fibroblastic
cell lines (15, 16).
MAPKs are subdivided into three major pathways (17). Extracellular
signal regulated kinases 1 and 2 (ERKs) are stimulated by growth
factors and cytokines and stimulate growth and differentiation. The
proto-oncogene c-ras and the cytoplasmic kinases c-Raf and MEK are known to play important roles in the activation of ERKs (18-20). The other two MAPK pathways, c-Jun-NH2-terminal
kinase (JNK) (also known as stress-activated protein kinase) and p38 MAPK, are generally activated by stresses such as inflammatory cytokines, osmotic shock, or UV irradiation and may be involved in
inhibition of cell growth and/or apoptosis. The balance between these
pathways may be critical in determining cell fate (21).
The mechanisms of activation of ERKs by GPCRs remain controversial.
Responses to Gq-linked receptors are thought to involve both the - and  -subunits of G proteins, although the
q-dependent activation of protein kinase C
is thought to play the predominant role (3, 22). Response to both
Gi-linked (22, 23) and Gs-linked (12) receptors
are thought to be due primarily to release of  -subunits, although
other mechanisms have also been proposed (12, 24). Similar mechanisms
have been implicated in activation of JNK/SAPK by GPCRs (24, 25), and
GPCR activation of p38 MAPK was recently suggested to involve
G q- as well as  -subunits (26).  -Dependent
activation of p38 MAPK is inhibited by coexpression of
G o in HEK 293 cells (26).
PC12 cells, derived from a rat pheochromocytoma, have been a primary
model for studying mechanisms underlying neuronal differentiation (27).
Nerve growth factor (NGF) acts on receptors with tyrosine kinase
activity to differentiate these cells into a neuronal phenotype, through a Ras-dependent activation of ERKs (28).
Stimulation of both bradykinin (Gq/11-coupled) and
lysophosphatidic acid (Gi-coupled) receptors also activates
ERKs in PC12 cells, apparently through the tyrosine kinases Pyk2 (6)
and Src (8) in a Ras-dependent manner. cAMP analogs also
activate ERKs and potentiate NGF-induced neurite formation in PC12
cells (29). Thus, Gq/11-, Gi-, and Gs-linked receptors may all activate ERKs in this cell
line.
This raises questions about signaling specificity. If all three types
of G proteins can activate ERKs, albeit through different mechanisms,
do they have similar functional consequences? To what extent are known
second messengers involved in activation of the MAPK pathways? Are the
functional consequences of G protein activation similar to those of
tyrosine kinase receptor activation?
We wanted to directly address the specificity by which GPCRs activate
MAPK pathways in a single cell line and study their functional
consequences. To do this, we transfected PC12 cells with inducible
expression vectors coding for one of each of the three families
( 1A, 2A, and 1) of
adrenergic receptor (AR) subtypes (30, 31) to assess whether
Gq/11-, Gi-, and Gs-linked pathways
all activate ERKs in this cell line. ARs affect growth and
differentiation of a variety of cell types, although the mechanisms involved are not yet clear. All ARs are activated by norepinephrine (NE), but they initiate signals through different G proteins. 1-ARs increase PI hydrolysis and intracellular
Ca2+ through Gq/11, 2-ARs
inhibit adenylate cyclase through Gi, and -ARs stimulate
adenylate cyclase through Gs. We wanted to directly assess
which signaling pathways were linked to which MAPK pathways and
determine whether activation of any of these GPCRs would cause differentiation of PC12 cells.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Materials were obtained from the following
sources: Lac-Switch vector system from Stratagene (La Jolla, CA),
phentolamine mesylate from Ciba-Geigy (Summit, NJ), hygromycin B from
Boehringer Mannheim, BE 2254 ((2- -(4-hydroxyphenyl)ethylaminomethyl)-tetralone) from Beiersdorf
AG (Hamburg, Germany), cyanopindolol from Sandoz (Basel, Switzerland),
[3H]rauwolscine (60 Ci/mmol) and carrier-free
Na125I from Amersham Pharmacia Biotech,
[3H]inositol (20-40 Ci/mmol) from American Radiolabeled
Chemicals (St. Louis, MO), fetal bovine serum, Geneticin, and
trypsin/EDTA from Life Technologies, Inc.; and ( )norepinephrine
bitartrate, Dulbecco's modified Eagle's medium, penicillin,
streptomycin, and other chemicals from Sigma. The cDNA for the
human 1A-AR (32) was generously provided by Dr. G. Tsujimoto (National Children's Hospital, Tokyo, Japan), the cDNA
for the rat 1-AR (33) was provided by Dr. Curtis A. Machida (Oregon Regional Primate Research Center, Beaverton, OR), and
the cDNA for the human 2A-AR (34) was obtained from
ATCC (Manassas, VA). PC12 cells were obtained from Cindy Miranti and
Michael Greenberg (Harvard Medical School, Boston, MA). NGF was
generously provided by David Ginty (Johns Hopkins, Baltimore, MD).
Preparation of Expression Vectors--
The full-length AR
sequences were cloned into the multiple cloning site of the operator
vector (pOPRSVICAT) of the inducible Lac-Switch system. The
NotI fragment of pOPRSVICAT containing the chloramphenicol
acetyltransferase reporter gene was replaced with the multiple cloning
site of pBluescript KS+ (where an additional NotI site had
been inserted 5' to the XhoI site) to facilitate insertion
of the gene of interest (35).
Cell Culture--
Rat pheochromocytoma PC12 cells were
maintained in Dulbecco's modified Eagle's medium supplemented with
10% (v/v) horse serum, 5% fetal bovine serum, 10 mg/ml streptomycin,
and 100 units/ml penicillin at 37 °C in a humidified atmosphere with
5% CO2. Confluent cells were subcultured in a 1:3 ratio.
Where indicated, transfected cells were treated with 1 mM
IPTG for various time periods to induce receptor expression.
Transfection--
PC12 cells were co-transfected with the
LacSwitch repressor (p3'SS) and operator vectors by calcium phosphate
precipitation and propagated for several weeks in the presence of 250 µg/ml hygromycin and 500 µg/ml Geneticin to obtain resistant cells. Subclones expressing each of the different ARs were obtained by screening for cell lines that exhibited low constitutive and high inducible receptor levels by radioligand binding. Cells for radioligand binding and second messenger measurements were plated at lower ( ) antibiotic concentrations.
Radioligand Binding--
Confluent 100-mm plates of cells were
washed in phosphate-buffered saline (20 mM
NaPO4, 154 mM NaCl, pH 7.6) and harvested by
scraping. Cells were homogenized with a Polytron, and membranes collected by centrifugation at 30,000 × g for 10 min,
washed, and resuspended by homogenization. Receptor density was
determined by saturation analysis of specific antagonist radioligands.
Binding of [125I]BE 2254 ( 1;
[125I]BE), [125I]-iodocyanopindolol ( )
and [3H]rauwolscine ( 2) to membrane
preparations was performed as described previously (36-38). For
saturation analysis, increasing concentrations of radioligand
([125I]BE, 25-800 pM;
[125I]cyanopindolol, 10-300 pM;
[3H]rauwolscine, 200-4000 pM) were used.
Nonspecific binding was defined as binding in the presence of 10 µM phentolamine ( 1 or 2) or
50 µM isoproterenol ( ).
InsP Formation--
Accumulation of [3H]InsPs was
determined in confluent 35-mm dishes. Cells were treated with or
without 1 mM IPTG for 48 h and labeled with
myo-[3H]inositol (2mCi/plate) for 1-2 days.
Production of total [3H]InsPs in the presence of 10 mM LiCl was determined as described previously (35).
Results are expressed as percentage of hydrolysis of
[3H]inositol incorporated into lipid.
cAMP Accumulation--
cAMP accumulation was measured by the
[3H]adenine prelabeling technique in confluent 35-mm
dishes as described previously (37). Results are expressed as percent
conversion of incorporated [3H]ATP into
[3H]cAMP.
Western Blots--
Confluent cells were serum-starved for 2 h at 37 oC before treatment. Agonists were generally added
for 15 min, and cells were washed twice with ice-cold
phosphate-buffered saline and lysed in Nonidet P-40 lysis buffer
containing 137 mM NaCl, 20 mM Tris-Cl (pH 8), 1 mM MgCl2, 1 mM CaCl2,
1% Nonidet P-40, 2 mM phenylmethylsulfonyl fluoride, 20 mM sodium orthovanadate, 20 mM leupeptin, and
10 µg/ml aprotinin. 20 µg of total protein was subjected to
SDS-polyacrylamide gel electrophoresis, and proteins were transferred
to a nitrocellulose membrane. Activation of ERK1 and 2, JNK/SAPK, or
p38 MAPK was detected by blotting the membrane with phosphospecific
ERK, JNK/SAPK, or p38 MAPK antibodies (New England Biolabs) that
specifically recognize the activated, threonine, and tyrosine dually
phosphorylated forms. Blots were stripped and probed with
nonphosphospecific antibodies to the enzymes to control for protein
loading. Proteins were visualized using a horseradish
peroxidase-conjugated goat anti-rabbit IgG and by ECL (Amersham
Pharmacia Biotech).
 |
RESULTS |
Lack of Endogenous ARs in Parental PC12 Cells--
We used
radioligand binding and functional approaches to determine whether any
endogenous ARs are expressed in PC12 cells. Low levels of endogenous
2-ARs have been reported in PC12 cells (39), but we
found no detectable levels of any AR subtype in our PC12 cells. No
specific binding was detected in membrane preparations using the
antagonist radioligands [125I]BE ( 1-AR),
[3H]rauwolscine ( 2 -AR), or
[125I]cyanopindolol ( -AR) (<5 fmol/mg of protein,
data not shown). There was also no detectable stimulation of cAMP by
the -AR agonist isoproterenol, no inhibition of forskolin-stimulated
cAMP by the 2-AR agonist UK 14,304 (see also below), and
no stimulation of [3H]InsP formation by the
1-AR agonists phenylephrine or NE in parental PC12 cells
(data not shown). These data suggest that this is one of the few cell
lines that do not express measurable levels of any AR subtype.
Characterization of Stably Transfected PC12 Subclones--
PC12
cells were co-transfected with the lac repressor vector and the lac
operator vector containing either human 1A-, human 2A-, or rat 1-AR coding sequences.
Subclones expressing each receptor were screened for low constitutive
expression and inducibility by IPTG. Saturation analysis of specific
radioligand binding was used to measure receptor density. Several
subclones were isolated with inducible expression of 1A-
or 2A-ARs; however, we were unable to obtain subclones
showing inducible expression of 1-ARs. Several subclones
with constitutive expression of 1-ARs were isolated and
used for further studies. Constitutive and IPTG-induced receptor
density in selected subclones is summarized in Table I.
View this table:
[in this window]
[in a new window]
|
Table I
Adrenergic receptor density and properties in subclones of transfected
PC12 cells: effect of IPTG induction
PC12 cells were co-transfected with one of the three adrenergic
receptor cDNAs subcloned into the LacSwitch operator vector and
p3'SS as described in the text. Individual subclones were isolated and
propagated as described. Receptor density (Bmax) and
affinity (KD) was quantitated by saturation analysis
of radioligand ( 1A, [125I]BE 2254; 2A,
[3H]rauwolscine; 1,
[125I]iodocyanopindolol) binding to membranes from cells
treated with (+IPTG) or without ( IPTG) 1 mM IPTG for
48 h.
|
|
1A-AR Expression and Induction--
Three subclones
of PC12 cells expressing 1A-ARs were extensively
characterized (Fig. 1). Saturation
analysis of [125I]BE binding showed that each subclone
exhibited different levels of constitutive and IPTG-induced (1 mM, 48 h) receptor expression, with
1A-3 showing the highest degree of induction. The effect of NE on [3H]InsP formation was studied to ensure that
the expressed receptors were functional. Basal [3H]InsP
formation was similar in each subclone, and was not affected by
treatment with IPTG (Fig. 1). NGF caused small increases in [3H]InsP formation in each subclone, and this response
was unaffected by treatment with IPTG. On the other hand, NE increased
[3H]InsP formation in each subclone, and this response
was substantially increased by induction of receptor expression with
IPTG. NE-stimulated [3H]InsP formation was highly
correlated with receptor density, being highest in subclone 3, which
expressed the highest density of 1A-ARs and lowest in
subclone 9, which expressed the lowest density of 1A-ARs
(Fig. 1). 1A-AR activation had no effect on cAMP levels
(data not shown), showing an absence of cross-talk with Gi
or GS.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 1.
Radioligand binding and NE-stimulated
inositol phosphate formation in subclones of
1A-transfected PC12 cells. Cells were transfected
with the human 1A-AR in the LacSwitch vector system,
selected, and propagated as described under "Experimental
Procedures." Receptor density (top left) was determined in
subclones 3, 9, and 25 treated without (Ctl) or with
(Ind) 1 mM IPTG for 48 h by saturation
analysis of specific [125I]BE binding.
[3H]Inositol phosphate formation was determined in each
subclone with or without IPTG induction of receptor expression, in the
presence of vehicle (bottom left), 100 µM NE
(top right), or 100 ng/ml NGF (bottom right).
Each value is the mean ± S.E. of three experiments performed in
duplicate.
|
|
2A-AR Expression and Induction--
Two PC12
subclones showing inducible expression of 2A-AR
receptors ( 2A-2 and 2A-5) were
characterized extensively. Saturation analysis of
[3H]rauwolscine binding indicated similar levels of basal
and IPTG-induced receptor expression in each cell line. The
concentration-response curve for IPTG-stimulation of
2A-AR expression in subclone 5 is shown in Fig.
2. IPTG caused about a 7-fold increase in
receptor expression with an EC50 around 5-10
µM. Inhibition of forskolin-stimulated cAMP accumulation
in these cells by the 2-AR-selective agonist UK 14,304 was used to ensure that the expressed receptors were functional. As
expected, there was no effect of IPTG-induced receptor expression on
forskolin-stimulated cAMP accumulation (Fig. 2). However, the potency
of UK 14,304 in inhibiting forskolin-stimulated cAMP accumulation was
enhanced 5-7-fold by IPTG pretreatment (1 mM, 48 h).
Interestingly, the maximal inhibition of the forskolin response by UK
14,304 was not affected by IPTG, suggesting that the density of
2A-ARs in uninduced cells is sufficient for maximal inhibition. 2A-AR activation did not affect InsP
formation (data not shown), showing an absence of cross-talk with
Gq/11.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 2.
Radioligand binding and cAMP accumulation in
2A-5 PC12 subclone. Top, receptor
density was determined by saturation analysis of specific
[3H]rauwolscine binding in cells treated for
48 h with IPTG at the following concentrations: none ( ), 5 ( ), 10 ( ), 20 ( ), 50 ( ), 100 ( ), 1000 ( ), or 5000 ( ) µM IPTG. Bottom left,
concentration-response relationship for forskolin-stimulated
[3H]cAMP formation in cells treated without
( IPTG) or with (+IPTG) 1 mM IPTG
for 48 h. Bottom right,
concentration-dependent inhibition of 30 µM
forskolin-stimulated [3H]cAMP by UK 14,304 in the
same cells. Each value is the mean ± S.E. of three
experiments performed in duplicate.
|
|
1-AR Expression--
All
1-AR-expressing PC12 subclones that we isolated showed
constitutive receptor expression. Each subclone showed a receptor density around 200 fmol/mg of protein, which was not significantly altered by treatment with IPTG (1 mM, 48 h). Because
this receptor density is in the range of expression of the
1A-AR- and 2A-AR-expressing subclones, we
used the constitutive expression of subclone 1-3 to
study 1-AR responses in PC12 cells. Because the -AR
is not activated in the absence of ligand, we did not make further
attempts to isolate an inducible -AR PC12 cell line. Stimulation
with forskolin (30 µM) caused about a 10-fold increase in
cAMP accumulation in both parental PC12 cells and the
1-3 subclone (Fig. 3).
Stimulation with the -AR agonist isoproterenol (10 µM)
had no effect on cAMP accumulation in parental PC12 cells but caused a
significant 50-100% increase in the 1-3 subclone. UK
14,304 had no effect on forskolin-stimulated cAMP accumulation in
either parental PC12 cells or in the 1-3 subclone (Fig.
3), confirming the absence of endogenous 2-ARs. 1-AR activation also did not affect InsP formation (data
not shown), showing an absence of cross-talk with
Gq/11.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 3.
cAMP accumulation in untransfected PC12 cells
and in a subclone of PC12 cells transfected with the rat
1-AR. Data from untransfected parental PC12 cells
is shown in the top panel, and data from the
1-3 subclone is shown in the bottom panel.
[3H]cAMP accumulation was determined under basal
conditions (B) and after stimulation with isoproterenol
(ISO, 10 µM), forskolin (F, 30 µM), or forskolin + 10 µM UK 14,304 (F+UK) as described in the text. Each value is the mean ± S.E. of three individual determinations.
|
|
Activation of ERKs--
We studied the effect of NE on ERK
activation in PC12 cells expressing the different AR subtypes. Exposure
to NGF (100 ng/ml) caused activation of ERK 1 and 2 phosphorylation in
parental PC12 cells (Fig. 4), as well as
in PC12 cells expressing each of the AR subtypes ( 1A-3,
2A-5, and 1-3). Exposure to NE (100 µM) had no effect in parental PC12 cells but caused
activation of ERKs in the 1A-3 PC12 cells (Fig. 4). As
expected, the degree of activation of ERKs by NE was increased by
increasing 1A-AR expression with IPTG. NE also caused
ERK activation in 1-3 PC12 cells, although this effect
was not increased by IPTG, which does not increase 1-AR
expression in these cells. Surprisingly, NE had no effect on ERK
activation in 2A-5 PC12 cells, even after increasing
receptor density by IPTG exposure (Fig. 4). Blotting for total ERK
protein showed equivalent sample loading for each condition (Fig. 4).
To confirm the lack of 2A-AR-mediated ERK activation in
PC12 cells, the effect of NE was also tested on the 2A-2
subclone. Again, NGF increased ERK phosphorylation in this cell line,
whereas NE had no effect either with or without exposure to IPTG (data
not shown).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 4.
Activation of MAPK by NE and NGF in PC12 cell
subclones. Cells were treated with (+) or without ( ) 1 mM IPTG for 48 h; serum-starved for 2 h; treated
with vehicle (C), NE (100 µM), or NGF (100 ng/ml) for 15 min; lysed; and harvested as described. 20 µg of
protein from each sample was subjected to SDS-polyacrylamide gel
electrophoresis, transferred to nitrocellulose, and blotted for
activated phosphorylated MAPK (P-MAPK) or total MAPK
(MAPK) as described. Data from parental PC12 cells and
subclones transfected with each of the three AR subtypes are shown.
Data are representative of seven or more separate experiments.
|
|
Activation of JNK/SAPK--
Several GPCRs have also been shown to
activate JNK/SAPK in various cells (7, 40). Exposure to NGF (100 ng/ml)
caused a slight activation of JNK phosphorylation in
1A-3, 2A-2, and 1-3 PC12
cells (Figs. 5 and
6). Exposure to NE (100 µM)
caused a significant activation of JNK in the 1A-3 PC12
cells, and the effect of NE was markedly increased by increasing
1A-AR expression with IPTG (Fig. 5). NE had no
significant effect on JNK activation in 2A-2 or
1-3 PC12 cells, irrespective of IPTG pretreatment (Fig.
6).

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 5.
Activation of JNK/SAPK and p38 MAPK by NE and
NGF in 1A-3 PC12 cells. Cells were treated with
(+IPTG) or without ( IPTG) 1 mM IPTG
for 48 h; serum-starved for 2 h; treated with vehicle
(C), NE (100 µM), or NGF (100 ng/ml) for 15 min; lysed; and harvested as described. 20 µg of protein from each
sample was subjected to SDS-polyacrylamide gel electrophoresis,
transferred to nitrocellulose, and blotted for activated phosphorylated
JNK (P-JNK), activated phosphorylated p38 MAPK
(P-p38), or total p38 MAPK (p38) as described.
Data are representative of five or more separate experiments.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 6.
Summary of the effects of NE and NGF on
activation of MAPK pathways in PC12 cells stably expressing different
AR subtypes. The degree of activation of MAPK (P-MAPK),
JNK (P-JNK), and p38 MAPK (P-p38) by NE (100 µM) or NGF (100 ng/ml) was quantitated by densitometry of
Western blots. Data from PC12 cell subclones stably transfected with
1A-AR (top), 2A-AR
(middle), or 1-AR (bottom)
subtypes is shown. Each value is the mean ± S.E. of values from
3-7 experiments. Bars indicate basal intensity in the
absence of agonist (100%).
|
|
Activation of p38 MAPK--
GPCRs have also been shown to activate
p38 MAPK in certain cells (26). Exposure to NGF (100 ng/ml) caused only
a small activation of p38 MAPK phosphorylation in 1A-3,
2A-2, and 1-3 PC12 cells (Figs. 5 and 6).
Exposure to NE (100 µM) caused a significant activation
of p38 MAPK in the 1A-3 PC12 cells, and the effect of NE
was again markedly increased by increasing 1A-AR
expression with IPTG (Fig. 5). NE had no significant effect on p38 MAPK
activation in 2A-2 or 1-3 PC12 cells,
irrespective of IPTG pretreatment (Fig. 6). Blotting for total p38 MAPK
protein showed equivalent protein loading in all samples.
Summary of AR-mediated Activation of MAPK Pathways in PC12
Subclones--
Fig. 6 shows a summary of the effects of NE and NGF on
activation of ERKs, JNK/SAPK, and p38 MAPK in the 1A-3,
2A-2, 2A-5, and 1-3 PC12
subclones. NGF caused substantial increases in ERK activation and small
increases in JNK/SAPK and p38 MAPK activation in all cell lines
studied. NE caused an 8.6-fold activation of ERKs, 5.3-fold activation
of JNK/SAPK, and 2.2-fold increase in p38 MAPK activation in
IPTG-induced 1A-3 PC12 cells. NE caused no detectable
increase in activation of ERKs, JNK/SAPK, or p38 MAPK in either of the
2A PC12 subclones examined, either with or without IPTG
treatment. NE caused a 3-fold increase in ERK activation, but no
detectable increase in either JNK/SAPK or p38 MAPK in
1-3 PC12 cells.
Time Course of NE-stimulated ERK Activation in 1A
and 1-AR PC12 Cells--
Because activation of either
1A- or 1-ARs activated ERKs in PC12
cells, we compared the time course of the two responses. Fig.
7 shows that NE activation of
1A-ARs caused a large and sustained activation of ERKs,
which was highly dependent on receptor induction by IPTG. NE activation
of 1-ARs also caused sustained ERK activation.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 7.
Time course for NE activation of ERKs in PC12
subclones. 1A-3 PC12 cells were treated with ( ,
Induced) or without ( , Control) 1 mM IPTG for 48 h, and 1-3 cells ( )
were cultured without IPTG. Cells were serum-starved for 2 h,
treated with NE (100 µM) for 0-120 min, lysed, and
harvested as described. 20 µg of protein from each sample was
subjected to SDS-polyacrylamide gel electrophoresis, transferred to
nitrocellulose, and blotted for activated phosphorylated MAPK as
described. Data are representative of two separate experiments. The
degree of stimulation is expressed in arbitrary units and is relative
to basal intensity. The densitometer was adjusted for maximal
sensitivity to emphasize responses.
|
|
Differentiation of AR-expressing PC12 Cells--
Exposure of
1A-3 PC12 cells to either NE or NGF caused
differentiation of the cells within 36-48 h after exposure (Fig.
8). The extent of NE-induced
differentiation of 1A-3 PC12 cells was dependent on the
level of receptor expression. Cells expressing high levels of
1A-ARs (~300 fmol/mg of protein following induction with IPTG) displayed NE-induced differentiation similar to that observed with NGF alone, whereas cells expressing lower levels of
1A-ARs (~40 fmol/mg of protein, not induced with IPTG)
showed NE-induced differentiation only slightly higher than untreated cells. Exposure of IPTG-induced 1A-3 cells to both NE
and NGF caused differentiation levels (size and number of neurites)
greater than those caused by either agonist alone (Fig. 8), suggesting that differentiation in response to the two agonists is additive. Exposure of uninduced 1A-3 cells to both NE and NGF
caused differentiation similar to that of cells exposed to NGF alone,
confirming that the effects of NE and NGF are additive, not
synergistic.

View larger version (124K):
[in this window]
[in a new window]
|
Fig. 8.
Effects of NE and NGF on differentiation of
the 1A-3 subclone of PC12 cells. Cells were plated
on collagen-coated plates and treated without (A, C, E, and
G) or with (B, D, F, and H) 1 mM IPTG for 48 h to induce receptor expression. Before
treatment with agonists, the medium was replaced with Dulbecco's
modified Eagle's medium containing 1% horse serum. Cells were then
treated for 48 h with vehicle (A and B), 10 µM NE (C and D), 100 ng/ml NGF
(E and F), or NE + NGF (G and
H). Fresh NE was added every 24 h. A representative
field of cells is shown in each case.
|
|
NE treatment had no significant effect on the differentiation state of
either of the 2A-AR-expressing PC12 subclones (subclones 2 and 5), either with or without induction of receptor expression with
IPTG (1 mM, 48 h), in the presence or absence of NGF,
or at any time point examined (data not shown).
Exposure of 1-3 PC12 cells to NE for 24-36 h had little
visible effect on differentiation (Fig.
9). However, NE had a synergistic effect
on differentiation caused by NGF. Exposure to both NGF and NE for just
24 h caused differentiation of cells to levels higher than that
seen in cells exposed to either NGF or NE alone (Fig. 9).

View larger version (67K):
[in this window]
[in a new window]
|
Fig. 9.
Effects of NE and NGF on differentiation of
the 1-3 subclone of PC12 cells. Cells were plated
on collagen-coated plates. Before treatment with agonists, the medium
was replaced with Dulbecco's modified Eagle's medium containing 1%
horse serum. Cells werethe treated for 24-30 h with vehicle (A), 100 µM NE (B), 100 ng/ml NGF (C), or NE + NGF (D). Fresh NE was added every 24 h. A
representative field of cells is shown in each case.
|
|
 |
DISCUSSION |
In this report, we directly compare the effects of
G q/11, G i, and G S-coupled
ARs on mitogenic responses and differentiation of PC12 cells. ARs
affect growth and differentiation of many cells, although the subtypes
and mechanisms involved are not yet clear. PC12 cells have been widely
used to study the events involved in cellular differentiation (27). NGF
causes differentiation of PC12 cells through a sustained activation of
the Ras/Raf/ERK pathway (21, 28). We took advantage of the fact that
the three AR families selectively couple to three major G protein
families ( 1/Gq/11,
2/Gi, and /GS) to examine the
specificity with which these receptors activate MAPK in PC12 cells.
Because receptor density is critically important in signaling
specificity, we used an IPTG-inducible vector system to control
receptor expression within a range normally observed in many tissues.
We wanted to directly compare AR-mediated activation of
Gq/11, Gi, and GS on MAPK and
differentiation responses in the same cellular phenotype. PC12 cells
also allow direct comparison of signals generated by GPCRs and tyrosine
kinase receptors involved in growth, differentiation, and
apoptosis.
We found dramatic differences in the ability of the three AR families
to promote MAPK activation and differentiation of PC12 cells.
Stimulation of both 1A- and 1-ARs caused
ERK activation, whereas stimulation of 2A-ARs did not.
The activation of ERKs by 1A- and 1-ARs
was sustained and elevated even 1 h after stimulation. Only in
1A-AR transfected cells did NE cause significant
activation of the JNK/SAPK and p38 MAPK pathways. In addition, only the
1A-AR subtype caused PC12 differentiation in the absence
of other stimuli. Most surprisingly, activation of
2A-ARs at either low or high density had no effect on
ERK activation in PC12 cells, despite previous studies showing
activation of this pathway through the endogenous lysophosphatidic acid
receptor in these cells (6, 8).
Activation of 1A-ARs by NE caused a substantial
activation of ERKs in PC12 cells, and this effect was increased by IPTG
exposure, suggesting that it was proportional to receptor density. ERK
activation by 1A-ARs corresponded with a NE-induced
differentiation of these cells into a neuronal-like phenotype. In cells
expressing high levels of 1A-ARs, NE caused
differentiation indistinguishable from that caused by NGF.
Differentiation of 1A-AR cells exposed to both NGF and
NE was no more than additive and occurred on the same time scale as
that caused by NGF alone (36-48 h).
NE also caused a large activation of JNK/SAPK and a smaller activation
of p38 MAPK in 1A-transfected PC12 cells, and these responses were also increased by IPTG exposure.
1-AR-mediated activation of JNK/SAPK has been reported
in cardiomyocytes (40); however, activation of p38 MAPK by
1-ARs has not been reported previously. p38 MAPK has
been shown to be activated by Gq/11-coupled m1 muscarinic
receptors (26) and by activated forms of q (14). Activation of JNK/SAPK and p38 MAPK has previously been associated with
stress responses (17, 21); however, recent data in cardiomyocytes suggest a role for JNK in cell growth (40). In most cases, ERK, JNK/SAPK, and p38 MAPK pathways are activated by different stimuli (17), and 1A-transfected PC12 cells are unusual in
activation of these pathways by a single stimulus.
GPCRs coupling through i (including
2-ARs) were among the first GPCRs shown to activate ERKs
(1, 2, 4). Other i-coupled receptors, such as
lysophosphatidic acid receptors, have also been reported to activate
ERKs in PC12 cells (8). We were surprised to find that stimulation of
2A-ARs did not activate ERKs in PC12 cells, even at high
expression levels. Studies on inhibition of forskolin-stimulated cAMP
accumulation showed that the expressed 2A-ARs were
functional, and receptor density in the presence of IPTG was higher for
2A-ARs than either 1A- or
1-ARs (Table I). Although lysophosphatidic acid often
acts via i, it has also been reported to activate
q in PC12 cells (41, 42), and it could be causing at
least some of its effects via q in these cells.
The fact that 2A-ARs activate ERKs in fibroblastic cell
lines such as Rat1a cells (2, 4) in a PTX-sensitive manner but do not
activate ERKs in PC12 cells indicates that there are important
mechanistic differences in signaling between the cell types. Activation
of ERKs by Gi-linked receptors appears to be mediated by
 -subunits (3, 22, 23, 43), and recent work suggests that 
signaling is impaired in the presence of either t- or
o-subunits (3, 44, 45). o is selectively
expressed in brain and many neuronal cell lines, including PC12 cells
(39, 46, 47). Fibroblastic cell lines, such as NIH3T3 and Rat1a, express i2 and i3 but not
o (39). Because o is expressed selectively in PC12 cells, it may play a similar suppressive role in
 -mediated MAPK activation by 2A-ARs. Regardless,
our results show that ERK activation is not a universal response to
activation of Gi-coupled receptors in PC12 cells.
Release of  -subunits is also proposed to be important for ERK
activation by S-linked GPCRs, although the specificity
of these interactions in PC12 cells is not yet clear (12, 43, 48). The
effects of increased levels of cAMP on differentiation of PC12 cells
and activation of ERKs have been well studied (29, 49, 50). In most
other cell lines, increases in cAMP generally inhibit ERK activation
(15, 16), and PC12 cells are relatively unusual in that
forskolin-induced increases in cAMP activate ERKs (29, 49-51). This
study is one of the few examples of ERK activation in PC12 cells caused
by stimulation of an s-linked GPCR (rather than direct
increases in cAMP), which would involve signaling from both
S- and  -subunits. We observed sustained activation of ERKs upon stimulation of 1-ARs in PC12 cells without
observable differentiation in the absence of NGF. However,
1-AR activation strongly potentiated NGF-induced
differentiation, causing the appearance of neurites within 24 h
after addition of both NE and NGF. This is consistent with previous
studies suggesting that large increases in cAMP can alone cause
differentiation of PC12 cells, but smaller increases in cAMP only
potentiate growth factor-induced differentiation (52). Intracellular
nonmitochondrial Ca2+ pools have been shown to be necessary
for the synergistic effects of NGF and cAMP analogs on PC12 cell
differentiation (53).
Previous studies in which PC12 cells were transfected with activated
forms of G protein -subunits showed that activated forms of
q alone, but not of i or
o, were capable of differentiating PC12 cells (14).
Differentiation by q coincided with activation of JNK,
but ERK activation was not seen (14). The results using activated
S are less clear. One group reported that expression of
activated S caused proliferation of PC12 cells and
constitutive activation of cAMP dependent pathways (54), whereas
another group found that expression of activated S
caused differentiation of PC12 cells (55). Transfection of G protein
subunits into Cos7 cells showed that ERK activation may be due to
signaling from  rather than either q,
i, or S (3).
These results have some similarities to studies in cardiac and smooth
muscle, in which both 1- and -ARs are involved in growth and differentiation (56). In both cases, 1-ARs
dominate, causing rapid and divergent activation of MAPK pathways and
transcription (40, 56-60). Because stimulation of
1A-ARs activates ERKs, JNK/SAPK, and p38 MAPK and
promotes differentiation of PC12 cells, it will be interesting to
compare the signaling pathways involved with those in myocytes (13, 60,
61). Studies in cardiac and smooth muscle cells are generally performed
in primary cultures or in vivo, and PC12 cells may be a
useful alternative in defining the transcriptional effects of receptor
activation and how they relate to growth and differentiation.
This report shows that activations of 1-,
2-, and -ARs in transfected PC12 cells have different
effects on MAPK pathways and differentiation, suggesting a clear
specificity in activation of MAPK pathways. The marked stimulation of
all three MAPK pathways and differentiation by 1A-AR
activation may provide a useful system for studying the mechanisms by
which GPCRs control cellular growth and differentiation and the
relationship of these pathways to those activated by tyrosine kinase
receptors.
 |
FOOTNOTES |
*
This research was supported by National Institutes of Health
Grants NS32706 and NS23756 (to K. P. M.) and Fellowship NS09580 (to
N. G. W.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 404-727-5985;
Fax: 404-727-0365.
The abbreviations used are:
MAPK, mitogen-activated protein kinase; AR, adrenergic receptor; cAMP, cyclic
adenosine 3'5'-monophosphate; ERK, extracellular signal-regulated
kinase (also known as p42 and p44 MAPKs); GPCR, G protein-coupled
receptor; [125I]BE, [125I]BE 2254 ((2- -(4-hydroxyphenyl)ethylaminomethyl)-tetralone)InsP, inositol
phosphateIPTG, isopropylthiogalactoseJNK, c-Jun
NH2-terminal kinaseNE, norepinephrineNGF, nerve growth
factorSAPK, stress-activated protein kinase.
 |
REFERENCES |
-
Howe, L. R.,
and Marshall, C. J.
(1993)
J. Biol. Chem.
268,
20717-20720[Abstract/Free Full Text]
-
Alblas, J.,
van Corven, E. J.,
Hordijk, P. L.,
Milligan, G.,
and Moolenaar, W. H.
(1993)
J. Biol. Chem.
268,
22235-22238[Abstract/Free Full Text]
-
Crespo, P.,
Xu, H.,
Simonds, W. F.,
and Gutkind, J. S.
(1994)
Nature
369,
418-420[CrossRef][Medline]
[Order article via Infotrieve]
-
Winitz, S.,
Russell, M.,
Qian, N.-X.,
Gardner, A.,
Dwyer, L.,
and Johnson, G. L.
(1993)
J. Biol. Chem.
268,
19196-19199[Abstract/Free Full Text]
-
Van Bliesen, T.,
Hawes, B. E.,
Luttrell, D. K.,
Krueger, K. M.,
Touhara, K.,
Porfiri, E.,
Sakaue, M.,
Luttrell, L. M.,
and Lefkowitz, R. L.
(1995)
Nature
376,
781-784[CrossRef][Medline]
[Order article via Infotrieve]
-
Lev, S.,
Moreno, H.,
Martinez, R.,
Canoll, P.,
Peles, E.,
Musacchio, J. M.,
Plowman, G. D.,
and Schlessinger, J.
(1995)
Nature
376,
737-745[CrossRef][Medline]
[Order article via Infotrieve]
-
Coso, O. A.,
Chiariello, M.,
Kalinec, G.,
Kyriakis, J. M.,
Woodgett, J.,
and Gutkind, J. S.
(1995)
J. Biol. Chem.
270,
5620-5624[Abstract/Free Full Text]
-
Dikic, I.,
Tokiwa, G.,
Lev, S.,
Courtneidge, S. A.,
and Schlessinger, J.
(1996)
Nature
383,
547-550[CrossRef][Medline]
[Order article via Infotrieve]
-
Lopez-Ilasaca, M.,
Crespo, P.,
Pellici, P. G.,
Gutkind, J. S.,
and Wetzker, R.
(1997)
Science
275,
394-397[Abstract/Free Full Text]
-
Della Rocca, G. J.,
van Biesen, T.,
Daaka, Y.,
Luttrell, D. K.,
Luttrell, L. M.,
and Lefkowitz, R. J.
(1997)
J. Biol. Chem.
272,
19125-19132[Abstract/Free Full Text]
-
Sugden, P. H.,
and Clerk, A.
(1997)
Cell. Signal.
9,
337-351[CrossRef][Medline]
[Order article via Infotrieve]
-
Crespo, P.,
Cachero, T. G.,
Xu, N.,
and Gutkind, J. S.
(1995)
J. Biol. Chem.
270,
25259-25265[Abstract/Free Full Text]
-
Thorburn, J.,
and Thorburn, A.
(1994)
Biochem. Biophys. Res. Commun.
202,
1586-1591[CrossRef][Medline]
[Order article via Infotrieve]
-
Heasley, L. E.,
Storey, B.,
Fanger, G. R.,
Butterfield, L.,
Zamarripa, J.,
Blumberg, D.,
and Maue, R. A.
(1996)
Mol. Cell. Biol.
16,
648-656[Abstract]
-
Cook, S. J.,
and McCormick, F.
(1993)
Science
262,
1069-1072[Abstract/Free Full Text]
-
Wu, J.,
Dent, P.,
Jelinek, T.,
Wolfman, A.,
Weber, M. J.,
and Sturgill, T. W.
(1993)
Science
262,
1065-1069[Abstract/Free Full Text]
-
Robinson, M. J.,
and Cobb, M. H.
(1997)
Curr. Opin. Cell Biol.
9,
180-186[CrossRef][Medline]
[Order article via Infotrieve]
-
Williams, N. G.,
Roberts, T. M.,
and Li, P.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
2922-2926[Abstract/Free Full Text]
-
Williams, N. G.,
Paradis, H.,
Agarwal, S.,
Charest, D. L.,
Pelech, S. L.,
and Roberts, T. M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5772-5776[Abstract/Free Full Text]
-
Williams, N. G.,
and Roberts, T. M.
(1994)
Cancer Metastasis Rev.
13,
105-116[CrossRef][Medline]
[Order article via Infotrieve]
-
Xia, Z.,
Dickens, M.,
Rangeaud, J.,
Davis, R. J.,
and Greenberg, M. E.
(1995)
Science
270,
1326-1331[Abstract/Free Full Text]
-
Hawes, B. E.,
van Biesen, T.,
Koch, W. J.,
Luttrell, L. M.,
and Lefkowitz, R. J.
(1995)
J. Biol. Chem.
270,
17148-17153[Abstract/Free Full Text]
-
Koch, W. J.,
Hawes, B. E.,
Allen, L. F.,
and Lefkowitz, R. J.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
12706-12710[Abstract/Free Full Text]
-
Daaka, Y.,
Luttrell, L. M.,
and Lefkowitz, R. J.
(1997)
Nature
390,
88-91[CrossRef][Medline]
[Order article via Infotrieve]
-
Prasad, M. V. V. S. V.,
Dermott, J. M.,
Heasley, L. E.,
Johnson, G. L.,
and Dhanasekaran, N.
(1995)
J. Biol. Chem.
270,
18655-18659[Abstract/Free Full Text]
-
Yamauchi, J.,
Nagao, M.,
Kaziro, Y.,
and Itoh, H.
(1997)
J. Biol. Chem.
272,
27771-27777[Abstract/Free Full Text]
-
Wood, K. W.,
and Roberts, T. M.
(1992)
Biochim. Biophys. Acta
1155,
133-150
-
Lange-Carter, C. A.,
and Johnson, G. L.
(1994)
Science
265,
1458-1461[Abstract/Free Full Text]
-
Frodin, M.,
Peraldi, P.,
and van Obberghen, E.
(1994)
J. Biol. Chem.
269,
6207-6214[Abstract/Free Full Text]
-
Bylund, D. B.,
Eikenberg, D. C.,
Hieble, J. P.,
Langer, S. Z.,
Lefkowitz, R. J.,
Minneman, K. P.,
Molinoff, P.B.,
Ruffolo, R. R.,
and Trendelenberg, U. J.
(1994)
Pharmacol. Rev.
46,
121-136[Medline]
[Order article via Infotrieve]
-
Minneman, K. P.,
and Esbenshade, T. A.
(1994)
Annu. Rev. Pharmacol. Toxicol.
34,
117-133[Medline]
[Order article via Infotrieve]
-
Hirasawa, A.,
Horie, K.,
Tanaka, T.,
Takagaki, K.,
Murai, M.,
Yano, J.,
and Tsujimoto, G.
(1993)
Biochem. Res. Commun.
195,
902-909
-
Machida, C. A.,
Brunzow, J. R.,
Searles, R. P.,
van Tol, H.,
Tester, B.,
Neve, K. A.,
Teal, P.,
Nipper, V.,
and Civelli, O.
(1990)
J. Biol. Chem.
265,
12960-12965[Abstract/Free Full Text]
-
Kobilka, B. K.,
Matsui, H.,
Kobilka, T. S.,
Yang-Feng, T. L.,
Francke, U.,
Caron, M. G.,
Lefkowitz, R. J.,
and Regan, J. W.
(1987)
Science
238,
650-656[Abstract/Free Full Text]
-
Esbenshade, T. A.,
Han, C.,
Murphy, T. J.,
and Minneman, K. P.
(1993)
Mol. Pharmacol.
44,
76-86[Abstract]
-
Nasseri, A.,
and Minneman, K. P.
(1987)
Mol. Pharmacol.
32,
655-662[Abstract]
-
Zhong, H.,
and Minneman, K. P.
(1993)
Mol. Pharmacol.
44,
1085-1093[Abstract]
-
Gatti, G.,
Madeddu, L.,
Pandiella, A.,
Pozzan, T.,
and Meldolesi, J.
(1988)
Biochem. J.
255,
753-760[Medline]
[Order article via Infotrieve]
-
Duzic, E.,
and Lanier, S. M.
(1992)
J. Biol. Chem.
267,
24045-24052[Abstract/Free Full Text]
-
Ramirez, M. T.,
Sah, V. P.,
Zhao, X.-L.,
Hunter, J. J.,
Chien, K. R.,
and Brown, J. H.
(1977)
J. Biol. Chem.
272,
14057-14061[Abstract/Free Full Text]
-
Tigyi, G.,
Fischer, D. J.,
Sebok, A.,
Marshall, F.,
Dyer, D. L.,
and Miledi, R.
(1996)
J. Neurochem.
66,
549-558[Medline]
[Order article via Infotrieve]
-
Van Corven, E. J.,
Gooenink, A.,
Jalink, K.,
Eichholtz, T.,
and Moolenaar, W. H.
(1989)
Cell
59,
45-54[CrossRef][Medline]
[Order article via Infotrieve]
-
Faure, M.,
Voyno-Yasenetskaya, T. A.,
and Bourne, H. R.
(1994)
J. Biol. Chem.
269,
7851-7854[Abstract/Free Full Text]
-
Yamauchi, J.,
Kaziro, Y.,
and Itoh, H.
(1997)
J. Biol. Chem.
272,
7602-7607[Abstract/Free Full Text]
-
Ito, A.,
Satoh, T.,
Kaziro, Y.,
and Itoh, H.
(1995)
FEBS Lett.
368,
183-187[CrossRef][Medline]
[Order article via Infotrieve]
-
Baribay, J. L.,
Kozasa, T.,
Itoh, H.,
Tsukamoto, T.,
Matsuoka, M.,
and Kaziro, Y.
(1991)
Biochim. Biophys. Acta
1094,
193-199[Medline]
[Order article via Infotrieve]
-
Asano, T.,
Morishita, R.,
and Kato, K.
(1992)
J. Neurochem.
58,
2176-2181[Medline]
[Order article via Infotrieve]
-
Hamm, H.
(1998)
J. Biol. Chem.
273,
669-672[Free Full Text]
-
Gunning, P. W.,
Landreth, G. E.,
Bothwell, M. A.,
and Shooter, E. M.
(1981)
J. Cell Biol.
89,
240-245[Abstract/Free Full Text]
-
Damon, D. H.,
D'Amore, P. A.,
and Wagner, J. A.
(1990)
J. Cell Biol.
110,
1333-1339[Abstract/Free Full Text]
-
Traverse, S.,
Gomez, H.,
Paterson, H.,
Marshall, C.,
and Cohen, P.
(1992)
Biochem. J.
288,
351-355
-
Mark, M. D.,
and Storm, D. R.
(1977)
J. Biol. Chem.
272,
17238-17244[Abstract/Free Full Text]
-
Huang, C. M.,
Tsay, K. E.,
and Kao, L. S.
(1996)
J. Neurochem.
67,
530-539[Medline]
[Order article via Infotrieve]
-
Gaiddon, C.,
Boutillier, A.,
Monnier, D.,
Mercken, L.,
and Loeffler, J.
(1994)
J. Biol. Chem.
269,
22663-22671[Abstract/Free Full Text]
-
Kabir, A. M.,
Kozasa, T.,
Kaziro, Y.,
and Nakamura, S.
(1993)
Cell. Signalling
5,
443-452[CrossRef][Medline]
[Order article via Infotrieve]
-
Simpson, P. C.,
Kariya, K-I.,
Karns, L. R.,
Long, C. S.,
and Karliner, J. S.
(1991)
Mol. Cell. Biochem.
104,
35-43[Medline]
[Order article via Infotrieve]
-
Thorburn, A.,
Thorburn, J.,
Chen, S.-Y.,
Powers, S.,
Shubeita, H. E.,
Feramisco, J. R.,
and Chien, K. R.
(1993)
J. Biol. Chem.
268,
2244-2249[Abstract/Free Full Text]
-
LaMorte, V. J.,
Thorburn, J.,
Absher, D.,
Spiegel, A.,
Brown, J. H.,
Chien, K. R.,
Feramisco, J. R.,
and Knowlton, K. U.
(1994)
J. Biol. Chem.
269,
13490-13496[Abstract/Free Full Text]
-
Xin, X.,
Yang, N.,
Eckhart, A. D.,
and Faber, J. E.
(1997)
Mol. Pharmacol.
51,
764-775[Abstract/Free Full Text]
-
Bogoyevitch, M. A.,
Andersson, M. B.,
Gillespie-Brown, J.,
Clerk, A.,
Glennon, P. E.,
Fuller, S. J.,
and Sugden, P. H.
(1996)
Biochem. J.
314,
115-121
-
Sah, V. P.,
Hoshijima, M.,
Chien, K. R.,
and Brown, J. H.
(1996)
J. Biol. Chem.
271,
31185-31190[Abstract/Free Full Text]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Zhang and A. A. Abdel-Rahman
Inhibition of Nischarin Expression Attenuates Rilmenidine-Evoked Hypotension and Phosphorylated Extracellular Signal-Regulated Kinase 1/2 Production in the Rostral Ventrolateral Medulla of Rats
J. Pharmacol. Exp. Ther.,
January 1, 2008;
324(1):
72 - 78.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Gericke, P. Martinka, I. Nazarenko, P. B. Persson, and A. Patzak
Impact of {alpha}1-adrenoceptor expression on contractile properties of vascular smooth muscle cells
Am J Physiol Regulatory Integrative Comp Physiol,
September 1, 2007;
293(3):
R1215 - R1221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Askari, R. Diskin, M. Avitzour, R. Capone, O. Livnah, and D. Engelberg
Hyperactive Variants of p38{alpha} Induce, whereas Hyperactive Variants of p38{gamma} Suppress, Activating Protein 1-mediated Transcription
J. Biol. Chem.,
January 5, 2007;
282(1):
91 - 99.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. B. Gibson, M. C. Lawrence, C. J. Gibson, C. A. Vanderbilt, K. McGlynn, D. Arnette, W. Chen, J. Collins, B. Naziruddin, M. F. Levy, et al.
Inhibition of Glucose-Stimulated Activation of Extracellular Signal-Regulated Protein Kinases 1 and 2 by Epinephrine in Pancreatic {beta}-Cells.
Diabetes,
April 1, 2006;
55(4):
1066 - 1073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Peavy, K. B. Hubbard, A. Lau, R. B. Fields, K. Xu, C. J. Lee, T. T. Lee, K. Gernert, T. J. Murphy, and J. R. Hepler
Differential Effects of Gq{alpha}, G14{alpha}, and G15{alpha} on Vascular Smooth Muscle Cell Survival and Gene Expression Profiles
Mol. Pharmacol.,
June 1, 2005;
67(6):
2102 - 2114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Fabbro, A. Skorinkin, M. Grandolfo, A. Nistri, and R. Giniatullin
Quantal release of ATP from clusters of PC12 cells
J. Physiol.,
October 15, 2004;
560(2):
505 - 517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. KJAeR
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
Physiol Rev,
April 1, 2004;
84(2):
649 - 698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Lee, A. Robeva, Z. Chen, and K. P. Minneman
Mutational Uncoupling of {alpha}1A-Adrenergic Receptors from G Proteins Also Uncouples Mitogenic and Transcriptional Responses in PC12 Cells
J. Pharmacol. Exp. Ther.,
August 1, 2003;
306(2):
471 - 477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bierhaus, J. Wolf, M. Andrassy, N. Rohleder, P. M. Humpert, D. Petrov, R. Ferstl, M. von Eynatten, T. Wendt, G. Rudofsky, et al.
A mechanism converting psychosocial stress into mononuclear cell activation
PNAS,
February 18, 2003;
100(4):
1920 - 1925.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bouschet, V. Perez, C. Fernandez, J. Bockaert, A. Eychene, and L. Journot
Stimulation of the ERK Pathway by GTP-loaded Rap1 Requires the Concomitant Activation of Ras, Protein Kinase C, and Protein Kinase A in Neuronal Cells
J. Biol. Chem.,
February 7, 2003;
278(7):
4778 - 4785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kalyankrishna and K. U. Malik
Norepinephrine-Induced Stimulation of p38 Mitogen-Activated Protein Kinase Is Mediated by Arachidonic Acid Metabolites Generated by Activation of Cytosolic Phospholipase A2 in Vascular Smooth Muscle Cells
J. Pharmacol. Exp. Ther.,
February 1, 2003;
304(2):
761 - 772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Berkeley and A. I. Levey
Cell-Specific Extracellular Signal-Regulated Kinase Activation by Multiple G Protein-Coupled Receptor Families in Hippocampus
Mol. Pharmacol.,
January 1, 2003;
63(1):
128 - 135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Jiao, P. J. Gonzalez-Cabrera, L. Xiao, M. E. Bradley, P. W. Abel, and W. B. Jeffries
Tonic Inhibitory Role for cAMP in alpha 1a-Adrenergic Receptor Coupling to Extracellular Signal-Regulated Kinases 1/2
J. Pharmacol. Exp. Ther.,
October 1, 2002;
303(1):
247 - 256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Hague, P. J. Gonzalez-Cabrera, W. B. Jeffries, and P. W. Abel
Relationship between alpha 1-Adrenergic Receptor-Induced Contraction and Extracellular Signal-Regulated Kinase Activation in the Bovine Inferior Alveolar Artery
J. Pharmacol. Exp. Ther.,
October 1, 2002;
303(1):
403 - 411.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Greney, D. Urosevic, S. Schann, L. Dupuy, V. Bruban, J.-D. Ehrhardt, P. Bousquet, and M. Dontenwill
[125I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I1 Imidazoline Receptors
Mol. Pharmacol.,
July 1, 2002;
62(1):
181 - 191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Vanhoose, M. Emery, L. Jimenez, and D. G. Winder
ERK Activation by G-protein-coupled Receptors in Mouse Brain Is Receptor Identity-specific
J. Biol. Chem.,
March 8, 2002;
277(11):
9049 - 9053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Zentrich, S.-Y. Han, L. Pessoa-Brandao, L. Butterfield, and L. E. Heasley
Collaboration of JNKs and ERKs in Nerve Growth Factor Regulation of the Neurofilament Light Chain Promoter in PC12 Cells
J. Biol. Chem.,
February 1, 2002;
277(6):
4110 - 4118.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Wretman, A. Lionikas, U. Widegren, J. Lannergren, H. Westerblad, and J. Henriksson
Effects of concentric and eccentric contractions on phosphorylation of MAPKerk1/2 and MAPKp38 in isolated rat skeletal muscle
J. Physiol.,
August 15, 2001;
535(1):
155 - 164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Esposito, S. V. N. Prasad, A. Rapacciuolo, L. Mao, W. J. Koch, and H. A. Rockman
Cardiac Overexpression of a Gq Inhibitor Blocks Induction of Extracellular Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase Activity in In Vivo Pressure Overload
Circulation,
March 13, 2001;
103(10):
1453 - 1458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Liu and F. A. Gesek
{alpha}1-Adrenergic receptors activate NHE1 and NHE3 through distinct signaling pathways in epithelial cells
Am J Physiol Renal Physiol,
March 1, 2001;
280(3):
F415 - F425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sabri, E. Pak, S. A. Alcott, B. A. Wilson, and S. F. Steinberg
Coupling Function of Endogenous {alpha}1- and {beta}-Adrenergic Receptors in Mouse Cardiomyocytes
Circ. Res.,
May 26, 2000;
86(10):
1047 - 1053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Mulvaney and M. S. Roberson
Divergent Signaling Pathways Requiring Discrete Calcium Signals Mediate Concurrent Activation of Two Mitogen-activated Protein Kinases by Gonadotropin-releasing Hormone
J. Biol. Chem.,
May 5, 2000;
275(19):
14182 - 14189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhong, T. J. Murphy, and K. P. Minneman
Activation of Signal Transducers and Activators of Transcription by alpha 1A-Adrenergic Receptor Stimulation in PC12 Cells
Mol. Pharmacol.,
May 1, 2000;
57(5):
961 - 967.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. M. Short, J. L. Boyer, and R. L. Juliano
Integrins Regulate the Linkage between Upstream and Downstream Events in G Protein-coupled Receptor Signaling to Mitogen-activated Protein Kinase
J. Biol. Chem.,
April 21, 2000;
275(17):
12970 - 12977.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. C. Blaxall, A. C. Pellett, S. C. Wu, A. Pende, and J. D. Port
Purification and Characterization of beta -Adrenergic Receptor mRNA-binding Proteins
J. Biol. Chem.,
February 11, 2000;
275(6):
4290 - 4297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Cussac, A. Newman-Tancredi, V. Pasteau, and M. J. Millan
Human Dopamine D3 Receptors Mediate Mitogen-Activated Protein Kinase Activation Via a Phosphatidylinositol 3-Kinase and an Atypical Protein Kinase C-Dependent Mechanism
Mol. Pharmacol.,
November 1, 1999;
56(5):
1025 - 1030.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
N. L. Schramm and L. E. Limbird
Stimulation of Mitogen-activated Protein Kinase by G Protein-coupled alpha 2-Adrenergic Receptors Does Not Require Agonist-elicited Endocytosis
J. Biol. Chem.,
August 27, 1999;
274(35):
24935 - 24940.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Della Rocca, S. Maudsley, Y. Daaka, R. J. Lefkowitz, and L. M. Luttrell
Pleiotropic Coupling of G Protein-coupled Receptors to the Mitogen-activated Protein Kinase Cascade. ROLE OF FOCAL ADHESIONS AND RECEPTOR TYROSINE KINASES
J. Biol. Chem.,
May 14, 1999;
274(20):
13978 - 13984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Berts, H. Zhong, and K. P. Minneman
No Role for Ca++ or Protein Kinase C in Alpha-1A Adrenergic Receptor Activation of Mitogen-Activated Protein Kinase Pathways in Transfected PC12 Cells
Mol. Pharmacol.,
February 1, 1999;
55(2):
296 - 303.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. M. Lindquist, J. M. Fredriksson, S. Rehnmark, B. Cannon, and J. Nedergaard
beta 3- and alpha 1-Adrenergic Erk1/2 Activation Is Src- but Not Gi-mediated in Brown Adipocytes
J. Biol. Chem.,
July 21, 2000;
275(30):
22670 - 22677.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|